Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Yanfang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4091-7679; OpenAlex author ID A5100678573. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2013: 2 papers · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 14

  1. Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set. Last author DOI 10.1016/j.canlet.2024.216981↗
  2. Autologous ex vivo expanded NK cells combined with PD-1 inhibitor improved ascitic fluid immune microenvironment of peritoneal metastatic pancreatic cancer: a … Co-author PMID 36777837↗
  3. Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy. Last author DOI 10.3389/fimmu.2022.863346↗
  4. O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis. Co-author DOI 10.7150/ijbs.71520↗
  5. Stearoyl-CoA Desaturase 1 Potentiates Hypoxic plus Nutrient-Deprived Pancreatic Cancer Cell Ferroptosis Resistance. Co-author DOI 10.1155/2021/6629804↗
  6. Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section H… Co-author DOI 10.3389/fonc.2021.694933↗
  7. Progress in Animal Models of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.37529↗
  8. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness. Co-author DOI 10.1038/s41419-019-1956-8↗
  9. Retraction notice to "CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic… Co-author DOI 10.1016/j.acthis.2018.03.005↗
  10. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. Co-author DOI 10.1371/journal.pone.0158529↗
  11. The low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-lik… Co-author DOI 10.1155/2014/760303↗
  12. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hy… Co-author DOI 10.3892/or.2014.3298↗
  13. CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Co-author DOI 10.1016/j.acthis.2012.09.007↗
  14. Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like ce… Co-author DOI 10.1186/1475-2867-13-119↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haitao Zhu · 9 shared papers, 2013–2022 · strength 0.66
  2. Meng Guo · 3 shared papers, 2020–2023 · strength 0.47
  3. Jianming Zheng · 3 shared papers, 2020–2022 · strength 0.45
  4. Aihua Gong · 3 shared papers, 2019–2022 · strength 0.36
  5. Zhaoliang Su · 6 shared papers, 2013–2018 · strength 0.30
  6. Dongqing Wang · 5 shared papers, 2013–2018 · strength 0.25
  7. Shichen Zhang · 1 shared paper, 2024 · strength 0.22
  8. Lirong Zhang · 3 shared papers, 2014–2019 · strength 0.18
  9. Xiaobo Peng · 1 shared paper, 2023 · strength 0.18
  10. Ling Chen · 1 shared paper, 2023 · strength 0.18
  11. Xianbao Zhan · 1 shared paper, 2023 · strength 0.18
  12. Kaiwen Kong · 1 shared paper, 2020 · strength 0.16
  13. Jin Wang · 1 shared paper, 2022 · strength 0.16
  14. Xin Wang · 1 shared paper, 2022 · strength 0.15
  15. Mengqi Liu · 1 shared paper, 2022 · strength 0.15
  16. Zhengyang Zhang · 1 shared paper, 2021 · strength 0.13
  17. Jie Gao · 1 shared paper, 2021 · strength 0.13
  18. Dongqing Wang · 1 shared paper, 2021 · strength 0.13
  19. Guiling Ding · 1 shared paper, 2021 · strength 0.13
  20. Hongbo Chen · 1 shared paper, 2019 · strength 0.09
  21. Xin Fan · 1 shared paper, 2019 · strength 0.09
  22. Genbao Shao · 2 shared papers, 2013–2014 · strength 0.08
  23. Jianxin Zhang · 1 shared paper, 2016 · strength 0.05
  24. Dongqing Wang · 1 shared paper, 2014 · strength 0.04
  25. Qing Liu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.